company
as of 2026-07-01National Institute of Mental Health (NIMH)
at a glance
335 trials sponsored · 60 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
60 assets
AripiprazoleChlorpromazineClozapineFluphenazineHaloperidolMinocyclineOlanzapinePaliperidonePerphenazinePomaglumetadQuetiapineRisperidoneZiprasidone(relapse rate)1-hertz Repetitive Transcranial Magnetic Stimulation11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor18F-Fluoro-L-dopa2-way pager3-monthly monitoringAVL-3288Acceptance and Commitment Therapy (ACT)Active 1-Hertz Repetitive transcranial magnetic stimulationActive rTMS stimulationAdapted ENHANCE InterventionAerobic Exercise ProgramAerobic exerciseAnticholinergic DeprescriptionAntipsychoticAssertive Community Treatment (ACT)B12BEATBRAVE (Behavioral Response Against Violence Engagement)Behavioral trainingBehavioral training booster sessionsBenefits ManagementBenztropineBrain BasicsBrain TrainingBrainHQ Computerized Cognitive Training - Visual Perception Training ParadigmBrainWorksBridging groupsBrief PTSD treatmentBrokered Vocational RehabilitationBupropionCALMSCATCBHHCBHH+ATCBHH+SMTCBSST-CCTCBTproCDP-cholineCLUESCOMT GenotypingCReSSmicro handheld topography deviceCTI-TSCVL-562 (PF-06412562) 1 mgCVL-562 (PF-06412562) 15 mgCVL-562 (PF-06412562) 25 mgCVL-562 (PF-06412562) 4 mg
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Aripiprazole
drugsmall molecule
Chlorpromazine
drugsmall molecule
Clozapine
drugsmall molecule
Fluphenazine
drugsmall molecule
Haloperidol
drugsmall molecule
Minocycline
drugsmall molecule
Olanzapine
drugsmall molecule
Paliperidone
drugsmall molecule